The first implantation of the MOVE ® -C cervical artificial disc replacement was successfully performed by Dr. Contreras on March 15, 2024 in Mexico. Dr.

Results published in The Spine Journal showed an artificial cervical disc may yield improved clinical outcomes compared with anterior cervical discectomy and fusion for the treatment of single ...

“M6-C Artificial Cervical Disc: Seven-Year Outcomes for Single-Level Total Disc Replacement with a Novel Viscoelastic Artificial Cervical Disc” – abstract presentation by Dr. Todd Lanman.

The US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) approval for Dymicron to initiate a pivotal trial of its Triadyme-C cervical artificial disc, a ...

A Newport Beach spine surgery center is taking part in a clinical study to determine an expansion in the use of cervical artificial discs. The Disc Surgery Center is now enrolling patients for the ...

Five-year data for the M6-C artificial cervical disc published in The Spine Journal. M6-C and M6-L discs implantations reach 100,000 worldwide.

After receiving CE approval end of December 2019, the MOVE ® -C cervical artificial disc replacement established well in the market. The unique viscoelastic design of MOVE ® -C with proven ...

The global artificial cervical disc market is expected to reach $8.56b by 2032 at a compound annual growth rate of 15.10%, according to SNS Insider.

Artificial Disc Replacement Market is Expected to Grow at a CAGR of Nearly 11.0% During the Forecast Period 2019-2029 - PMR PRESS RELEASE PR Newswire Jun. 18, 2019, 07:00 AM ...

“M6-C Artificial Cervical Disc: Seven-Year Outcomes for Single-Level Total Disc Replacement with a Novel Viscoelastic Artificial Cervical Disc” – abstract presentation by Dr. Todd Lanman.